BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wu J, Xue R, Jiang RT, Meng QH. Characterization of metabolic landscape in hepatocellular carcinoma. World J Gastrointest Oncol 2021; 13(9): 1144-1156 [PMID: 34616519 DOI: 10.4251/wjgo.v13.i9.1144]
URL: https://www.wjgnet.com/1948-5204/full/v13/i9/1144.htm
Number Citing Articles
Arthur J. L. Cooper, Thambi Dorai, John T. Pinto, Travis T. Denton. Metabolic Heterogeneity, Plasticity, and Adaptation to “Glutamine Addiction” in Cancer Cells: The Role of Glutaminase and the GTωA [Glutamine Transaminase—ω-Amidase (Glutaminase II)] PathwayBiology 2023; 12(8): 1131 doi: 10.3390/biology12081131
Soo-Mi Kweon, Gayeoun Kim, Yunseong Jeong, Wendong Huang, Ju-Seog Lee, Keane K. Y. Lai. Midnolin Regulates Liver Cancer Cell Growth In Vitro and In VivoCancers 2022; 14(6): 1421 doi: 10.3390/cancers14061421
Renumathy Dhanasekaran, Hiroyuki Suzuki, Lea Lemaitre, Naoto Kubota, Yujin Hoshida. Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-makingHepatology 2023;  doi: 10.1097/HEP.0000000000000513
Amna Hafeez, Zeeshan Khan, Muhammad Armaghan, Khushbukhat Khan, Eda Sönmez Gürer, Ahmad Faizal Abdull Razis, Babagana Modu, Zainab M. Almarhoon, William N. Setzer, Javad Sharifi-Rad. Exploring the therapeutic and anti-tumor properties of morusin: a review of recent advancesFrontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1168298
Anna Gajos-Michniewicz, Malgorzata Czyz. WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunitiesGenes & Diseases 2024; 11(2): 727 doi: 10.1016/j.gendis.2023.02.050
NP Syamprasad, Siddhi Jain, Bishal Rajdev, Neethu Prasad, Ravindra Kallipalli, V.G.M. Naidu. Aldose reductase and cancer metabolism: The master regulator in the limelightBiochemical Pharmacology 2023; 211: 115528 doi: 10.1016/j.bcp.2023.115528